Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …

Molecular Dynamics (MD) Simulations is increasingly used as a powerful tool to study
protein structure-related questions. Starting from the early simulation study on the …

Background Aging influences COVID-19 severity and response to vaccination, but previous
vaccine effectiveness (VE) analyzes lack the power to evaluate its role in subgroups within …

The SARS‐CoV‐2 omicron variant (B. 1.1. 529) was first identified in Botswana and South
Africa, and its emergence has been associated with a steep increase in the number of SARS …

The emergence and rapid spread of the monkeypox virus (MPXV) to non-endemic countries
has brought this once obscure pathogen to the forefront of global public health. Given the …

With the atypical rise of Mycoplasma pneumoniae infection (MPI) in 2023, prompt studies
are needed to determine the current epidemic features and risk factors with emerging trends …

Abstract Coronavirus disease 2019 (COVID-19) has a devastating impact on global
populations triggered by a highly infectious viral sickness, produced by the severe acute …

Objective Mortality rates of pregnant and postpartum women grew in the second COVID-19
pandemic year. Our objective is to understand this phenomenon to avoid further deaths …

Since its initial detection in Brazil in February 2020, SARS-CoV-2 and the associated COVID-
19 pandemic have continued to devastate Latin America. Specific comorbidities, as well as …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has undergone multiple
mutations since its emergence, and its latest variant, Omicron (B. 1.1. 529), is the most …